Evaluation criteria

The nominee for the Daniel B. Smith Practice Excellence Award must be a pharmacist who is a member of APhA, and a pharmacy practitioner in any practice setting who has distinguished himself/herself and the profession of pharmacy by sustained outstanding performance and achievement. Remington Honor Medalists are not eligible for the award. Nomination and recommendation letters should include a description of the nominee’s impact on practice and the profession. Applications will be evaluated based upon the following criteria (listed alphabetically; not in rank order):

APhA related activities (leadership, committees, speaker, publication contributor/reviewer, etc.)

Awards and recognition (state/national/university)

Community service (government, religious, civic, etc.)

Impact on the nominee’s area of practice and on the profession (innovative practice, scholarly activities)

Participation in other professional associations (leadership, committee, etc.)

Nomination process

The nominator is responsible for submitting a complete award nomination.

The nomination is to include the following items:

A letter from the nominator describing the most important achievements of the nominee and explaining why the nominee meets the criteria for the award

One letter of recommendation is required; a maximum of two letters accepted

A current curriculum vitae or detailed résumé

Selection process

The selection is made by the APhA Pharmacist Awards Selection Committee based upon careful review of complete nominations and criteria as listed above.

Nature of award

The award, to be presented at the APhA Annual Meeting & Exposition, consists of a 14K gold diamond ring in a presentation case. The recipient will also receive a complimentary APhA Annual Meeting & Exposition registration and reimbursement for meeting-related travel expenses, according to current travel policies and up to the maximum amount budgeted by APhA. The award is endowed by Bristol-Meyer Squibb Company.